Metabolic Syndrome Prevalence Study


Following the first study conducted to investigate the prevalence of metabolic syndrome and its components in Turkey, it was aimed to demonstrate the change in general health condition of available patients after the period of time lapsed. This study will provide important information on the social and economic dimensions of metabolic syndrome and will contribute to development of preventive programs.

Full Title of Study: “Turkey Metabolic Syndrome Prevalence Study – METSAR II”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: November 2014

Detailed Description

In the first METSAR-I study conducted in 2003, metabolic syndrome screening was made by two different team. Participants were visited at their addresses and informed about the research study and gave written consent. They were invited on an empty stomach for hospital visit on the day after. Pre-trained nurses completed the forms of patients during that second visit. After 11 years, a questionnaire by telephone survey will be applied to patients who participated in the METSAR-II study. The main goal is to determine the changes of metabolic syndrome population during that period.


  • Other: Metabolic Syndrome
    • This study will provide important information on the social and economic dimensions of metabolic syndrome

Clinical Trial Outcome Measures

Primary Measures

  • comorbidities and changes in general health
    • Time Frame: 10 year

Participating in This Clinical Trial

Inclusion Criteria

  • Volunteers who participated in the METSAR-I study in 2003
  • Patients who accepted to participate will be included the second follow up phase.

Exclusion Criteria


Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Abdi Ibrahim Ilac San. ve Tic A.S.
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Omer Kozan, Study Director, Dokuz Eylul University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.